Delivering Antisense Oligonucleotides across the Blood‐Brain Barrier by Tumor Cell‐Derived Small Apoptotic Bodies
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
Delivering Antisense Oligonucleotides across the Blood‐Brain Barrier by Tumor Cell‐Derived Small Apoptotic Bodies ; day:04 ; month:05 ; year:2021 ; extent:13
Advanced science ; (04.05.2021) (gesamt 13)
- Urheber
-
Wang, Yulian
Pang, Jiayun
Wang, Qingyun
Yan, Luocheng
Wang, Lintao
Xing, Zhen
Wang, Chunming
Zhang, Junfeng
Dong, Lei
- DOI
-
10.1002/advs.202004929
- URN
-
urn:nbn:de:101:1-2021050515084424974780
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:47 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Wang, Yulian
- Pang, Jiayun
- Wang, Qingyun
- Yan, Luocheng
- Wang, Lintao
- Xing, Zhen
- Wang, Chunming
- Zhang, Junfeng
- Dong, Lei
Ähnliche Objekte (12)
Systemic Brain Delivery of Antisense Oligonucleotides across the Blood–Brain Barrier with a Glucose‐Coated Polymeric Nanocarrier
Systemic Brain Delivery of Antisense Oligonucleotides across the Blood–Brain Barrier with a Glucose‐Coated Polymeric Nanocarrier
Tritium labeling of antisense oligonucleotides via different conjugation agents
Gephyrin antisense oligonucleotides prevent glycine receptor clustering in spinal neurons
Minimal structural modifications of antisense oligonucleotides conveying stability towards endonucleases
Splice-Modulating Antisense Oligonucleotides as Therapeutics for Inherited Metabolic Diseases
Respirable antisense oligonucleotides: a new drug class for respiratory disease
Antisense oligonucleotides: recent progress in the treatment of various diseases
Splicing modulation via antisense oligonucleotides in recessive dystrophic epidermolysis bullosa
Mismatched single stranded antisense oligonucleotides can induce efficient dystrophin splice switching
Intracellular Delivery of Antisense Oligonucleotides by Tri‐Branched Cyclic Disulfide Units
Engineering Antisense Oligonucleotides for Site-directed RNA Editing with Endogenous ADAR
Systemic Brain Delivery of Antisense Oligonucleotides across the Blood–Brain Barrier with a Glucose‐Coated Polymeric Nanocarrier
Systemic Brain Delivery of Antisense Oligonucleotides across the Blood–Brain Barrier with a Glucose‐Coated Polymeric Nanocarrier
Tritium labeling of antisense oligonucleotides via different conjugation agents
Gephyrin antisense oligonucleotides prevent glycine receptor clustering in spinal neurons
Minimal structural modifications of antisense oligonucleotides conveying stability towards endonucleases
Splice-Modulating Antisense Oligonucleotides as Therapeutics for Inherited Metabolic Diseases
Respirable antisense oligonucleotides: a new drug class for respiratory disease
Antisense oligonucleotides: recent progress in the treatment of various diseases
Splicing modulation via antisense oligonucleotides in recessive dystrophic epidermolysis bullosa
Mismatched single stranded antisense oligonucleotides can induce efficient dystrophin splice switching
Intracellular Delivery of Antisense Oligonucleotides by Tri‐Branched Cyclic Disulfide Units
Engineering Antisense Oligonucleotides for Site-directed RNA Editing with Endogenous ADAR
Systemic Brain Delivery of Antisense Oligonucleotides across the Blood–Brain Barrier with a Glucose‐Coated Polymeric Nanocarrier
Systemic Brain Delivery of Antisense Oligonucleotides across the Blood–Brain Barrier with a Glucose‐Coated Polymeric Nanocarrier
Tritium labeling of antisense oligonucleotides via different conjugation agents
Gephyrin antisense oligonucleotides prevent glycine receptor clustering in spinal neurons
Minimal structural modifications of antisense oligonucleotides conveying stability towards endonucleases
Splice-Modulating Antisense Oligonucleotides as Therapeutics for Inherited Metabolic Diseases
Respirable antisense oligonucleotides: a new drug class for respiratory disease
Antisense oligonucleotides: recent progress in the treatment of various diseases
Splicing modulation via antisense oligonucleotides in recessive dystrophic epidermolysis bullosa
Mismatched single stranded antisense oligonucleotides can induce efficient dystrophin splice switching
Intracellular Delivery of Antisense Oligonucleotides by Tri‐Branched Cyclic Disulfide Units